Ignite Creation Date:
2025-12-24 @ 1:57 PM
Ignite Modification Date:
2026-01-02 @ 1:27 PM
Study NCT ID:
NCT00517595
Status:
COMPLETED
Last Update Posted:
2012-03-12
First Post:
2007-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC
Sponsor:
Organization: